fate stock price target

The 5 analysts offering 12-month price forecasts for Vyne Therapeutics Inc have a median target of 500 with a high estimate of 1000 and a low estimate of 300. March 14 2022.

Apple S Stock May Rise 8 On Strong Growth

FATE is higher by 060 from the previous closing.

. Find the latest Fate Therapeutics Inc. The average price target for FATE is 80214 and analysts rate the stock as a Strong Buy Wall Street analysts are rating FATE a Strong Buy today. FATE has a beta value of 176 and an average true range ATR of 246.

According to analysts consensus price target of 8722 Fate Therapeutics has a forecasted upside of 2676 from its current price of 2373. FATE stock quote history news and other vital information to help you with your stock trading and investing. FATE reports an average of 12469 for its upside potential over the past 48 weeks.

Fate still must complete its phase 1 studies of both FT516 and FT596. Further Fate Therapeutics Inc. Find the latest Fate Therapeutics Inc FATE stock price forecast 12-month price target predictions and analyst recommendations.

In-depth view of key statistics and finances for FATE THERAPEUTICS INC. 13500 Spread Highest target. Fate Therapeutics price target lowered to 75 from 125 at Truist Truist analyst Robyn Karnauskas.

9189 Spread Average Target. FATE on MSN Money. Based on 8 Wall Street analysts offering 12 month price targets for Fate Therapeutics in the last 3 months.

Assuming all goes well it will then advance the experimental immunotherapies into phase 2 testing. 47 rows Close price at the end of the last trading day Friday 20th May 2022. Date Number of Analysts.

Discover the Power of thinkorswim Today. 1 Year Price Target. According to the issued ratings of 10 analysts in the last year the consensus rating for Fate Therapeutics stock is Buy based on the current 2 hold ratings and 8 buy ratings.

128 rows This price target is based on 9 analysts offering 12 month price targets for Fate. Based on the current price of 2047 the target price of 8500 shows a potential of 315242 for Fate Therapeutics Inc. FATE stock discussion in Yahoo Finances forum.

View the latest Fate Therapeutics Inc. Evolution of the average Target Price on FATE THERAPEUTICS INC. Find the latest Fate Therapeutics Inc.

Find out what this means. Ad Our Strong Buys Double the SP. Become a member for free.

Fate Therapeutics Inc FATE stock has gained 102 while the SP 500 is lower by -166 as of 130 PM on Monday Dec 20. At the last closing Fate Therapeutics Incs. FATE stock price news historical charts analyst ratings and financial information from WSJ.

Which would more than double the current price. Find real-time FATE - Fate Therapeutics Inc stock quotes company profile news and forecasts from CNN Business. Fate Therapeutics reported interim results from 14 patients treated with FT596 an off-the-shelf immunotherapy made of natural killer cells engineered to target CD19.

5 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 8720 with the highest FATE stock price forecast at 11500 and the. High Price Target. Amount of Analyst Coverage.

Over the past 22 months FATEs average price target has gone up 5607. Among 10 analysts who have 12-month price forecasts on ContextLogic stock the median price target is 1750 with a high estimate of 2400 per share. The average price target is 7643 with a high forecast of 11500 and a low forecast.

Stock Target Advisors own stock analysis of Fate Therapeutics Inc is Slightly Bearish which is based on 3 positive signals and 4 negative signals. Access Our Full Suite of Innovative Award-Winning Trading Platforms Built for Traders. Analysts have given the companys stock an average 52-week price.

Based On Fundamental Analysis.

Ctxr Citius Pharmaceuticals One Of Most Talked About Penny Stock Today 6 Target Price By Analyst Tech Stocks Penny Analyst

Fate Stock Price And Chart Nasdaq Fate Tradingview

Fate Fate Therapeutics Inc Stock Overview U S Nasdaq Barron S

Fate Stock Price And Chart Nasdaq Fate Tradingview

Fate Fate Therapeutics Inc Stock Overview U S Nasdaq Barron S

Apple Store

Roblox Stock Price Forecast 2022 Will This Metaverse Stock Rebound

Trading

Price Action Setups Gbpnzd Nzdjpy And Audusd Daily Price Action Setup Stock Market To Focus

Bidness Sheds Light On Stifel S Decision To Initiate Coverage On Solarcity Corp Nasdaq Scty Stock With A Buy Rating An Hot Tub Cover Business Finance Company